3.68
price down icon2.90%   -0.11
after-market Dopo l'orario di chiusura: 3.75 0.07 +1.90%
loading
Precedente Chiudi:
$3.79
Aprire:
$3.78
Volume 24 ore:
9.80M
Relative Volume:
4.88
Capitalizzazione di mercato:
$630.92M
Reddito:
$25.55M
Utile/perdita netta:
$-341.97M
Rapporto P/E:
-1.3143
EPS:
-2.8
Flusso di cassa netto:
$-304.44M
1 W Prestazione:
+0.82%
1M Prestazione:
+11.18%
6M Prestazione:
-24.12%
1 anno Prestazione:
-58.79%
Intervallo 1D:
Value
$3.68
$3.87
Intervallo di 1 settimana:
Value
$3.50
$3.87
Portata 52W:
Value
$1.775
$10.72

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Nome
Relay Therapeutics Inc
Name
Telefono
617-370-8837
Name
Indirizzo
399 BINNEY STREET, CAMBRIDGE
Name
Dipendente
259
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-21
Name
Ultimi documenti SEC
Name
RLAY's Discussions on Twitter

Confronta RLAY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RLAY
Relay Therapeutics Inc
3.68 636.06M 25.55M -341.97M -304.44M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-17 Iniziato Wells Fargo Equal Weight
2024-09-10 Ripresa Goldman Buy
2024-09-10 Aggiornamento Jefferies Hold → Buy
2024-09-10 Downgrade Oppenheimer Outperform → Perform
2024-05-10 Aggiornamento Barclays Equal Weight → Overweight
2023-04-20 Aggiornamento Jefferies Underperform → Hold
2023-04-19 Aggiornamento Raymond James Outperform → Strong Buy
2023-04-13 Iniziato Raymond James Outperform
2023-02-03 Iniziato Oppenheimer Outperform
2022-09-30 Iniziato Barclays Equal Weight
2022-09-02 Iniziato Stifel Buy
2022-06-06 Iniziato Jefferies Underperform
2022-02-01 Iniziato Berenberg Buy
2021-07-21 Iniziato BofA Securities Buy
2020-12-15 Reiterato H.C. Wainwright Buy
2020-12-08 Iniziato JMP Securities Mkt Outperform
2020-11-05 Iniziato H.C. Wainwright Buy
2020-08-10 Iniziato Cowen Outperform
2020-08-10 Iniziato Goldman Buy
2020-08-10 Iniziato Guggenheim Buy
2020-08-10 Iniziato JP Morgan Neutral
Mostra tutto

Relay Therapeutics Inc Borsa (RLAY) Ultime notizie

pulisher
Jul 24, 2025

When is the best time to buy Relay Therapeutics Inc. stockMassive wealth growth - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Will Relay Therapeutics Inc. stock benefit from AI tech trendsFree Stock Index Interpretation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Relay Therapeutics Inc. stock priceTremendous growth potential - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Relay Therapeutics Inc. stockHigh-margin investment plays - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Relay Therapeutics Inc. a good long term investmentFree Risk Assessment Services - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Relay Therapeutics Inc. Stock Analysis and ForecastExceptional earning trajectories - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Relay Therapeutics Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

what makes relay therapeutics inc. stock price move sharplyTargeted 200 Percent Gain - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Relay Therapeutics Inc. stock overhyped or has real potentialLong Term Secure Gain Stocks - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Relay Therapeutics Inc. stock a good hedge against inflationFree Stock Market Insider Analysis - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

RLAY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

How Relay Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Relay Therapeutics Inc. stock price move sharplyTrade Ready Signal - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

DekaBank Deutsche Girozentrale Raises Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Jul 15, 2025
pulisher
Jul 12, 2025

Have Relay Therapeutics Insiders Been Selling Stock? - simplywall.st

Jul 12, 2025
pulisher
Jul 12, 2025

Wealth Enhancement Advisory Services LLC Makes New $41,000 Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

AI drug discovery platform Market May See a Big Move | Major Giants - openPR.com

Jul 11, 2025
pulisher
Jul 10, 2025

Relay Therapeutics CEO Patel sells $219k in shares By Investing.com - Investing.com Canada

Jul 10, 2025
pulisher
Jul 05, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jul 05, 2025
pulisher
Jul 02, 2025

Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process? - The Globe and Mail

Jul 02, 2025
pulisher
Jun 24, 2025

BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT - Yahoo Finance

Jun 24, 2025
pulisher
Jun 23, 2025

13 Best Long-Term Penny Stocks to Buy According to Analysts - Insider Monkey

Jun 23, 2025
pulisher
Jun 20, 2025

With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology - PR Newswire

Jun 20, 2025
pulisher
Jun 19, 2025

Unraveling Relay Therapeutics' 9.8% Spike: A Closer Look at the Anomaly - AInvest

Jun 19, 2025
pulisher
Jun 18, 2025

In the Green: Relay Therapeutics Inc (RLAY) Closes at 3.06, Up/Down -6.42 from Previous Day - DWinneX

Jun 18, 2025
pulisher
Jun 14, 2025

Relay Therapeutics’ SWOT analysis: AI-driven drug discovery stock faces pivotal phase - Investing.com India

Jun 14, 2025
pulisher
Jun 12, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by California State Teachers Retirement System - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

# Relay Therapeutics appoints Bicara CEO to board ahead of breast cancer trial - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors | RLAY Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Relay Therapeutics Appoints Claire Mazumdar to Board of Directors - citybiz

Jun 11, 2025

Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):